| 0 |
POST CARDIAC ARREST SYNDROME |
1 |
0.0357 |
| 1 |
THYROID STIMULATING IMMUNOGLOBULIN |
1 |
0.0323 |
| 2 |
POST VACCINATION SYNDROME |
1 |
0.0323 |
| 3 |
KALEIDOSCOPE VISION |
1 |
0.0312 |
| 4 |
FEMALE SEX HORMONE LEVEL ABNORMAL |
1 |
0.0227 |
| 5 |
LIMB PROSTHESIS USER |
1 |
0.0185 |
| 6 |
INTERVENTRICULAR SEPTUM RUPTURE |
1 |
0.0179 |
| 7 |
FORCED EXPIRATORY VOLUME INCREASED |
1 |
0.0169 |
| 8 |
AUTOPHONY |
1 |
0.0133 |
| 9 |
APPLICATION SITE ECZEMA |
1 |
0.0115 |
| 10 |
INTESTINAL CONGESTION |
1 |
0.0096 |
| 11 |
GRIP STRENGTH |
2 |
0.0087 |
| 12 |
POST VIRAL FATIGUE SYNDROME |
2 |
0.0083 |
| 13 |
ANTI-THYROID ANTIBODY INCREASED |
1 |
0.0079 |
| 14 |
HYPERVITAMINOSIS |
1 |
0.0072 |
| 15 |
VASCULAR FRAGILITY |
1 |
0.0064 |
| 16 |
BIOPSY BREAST |
2 |
0.0064 |
| 17 |
ATRIAL SEPTAL DEFECT REPAIR |
1 |
0.0058 |
| 18 |
BRAIN STEM ISCHAEMIA |
1 |
0.0056 |
| 19 |
BREAST LUMP REMOVAL |
1 |
0.0044 |
| 20 |
TYPE V HYPERLIPIDAEMIA |
2 |
0.0041 |
| 21 |
SLEEVE GASTRECTOMY |
1 |
0.0041 |
| 22 |
SWOLLEN JOINT COUNT |
1 |
0.0040 |
| 23 |
ENDOMETRIAL THICKENING |
2 |
0.0036 |
| 24 |
IMMATURE GRANULOCYTE COUNT INCREASED |
1 |
0.0035 |
| 25 |
VASCULAR DEVICE OCCLUSION |
1 |
0.0029 |
| 26 |
TOOTH DEPOSIT |
1 |
0.0029 |
| 27 |
MILIA |
1 |
0.0028 |
| 28 |
GINGIVAL ABSCESS |
2 |
0.0027 |
| 29 |
LIPID METABOLISM DISORDER |
1 |
0.0026 |
| 30 |
CARDIOVASCULAR SYMPTOM |
1 |
0.0026 |
| 31 |
MENOPAUSAL SYMPTOMS |
6 |
0.0026 |
| 32 |
ENDOMETRIAL HYPERPLASIA |
2 |
0.0025 |
| 33 |
ENDOMETRIAL DISORDER |
1 |
0.0024 |
| 34 |
SCIATIC NERVE INJURY |
2 |
0.0024 |
| 35 |
COVID-19 IMMUNISATION |
2 |
0.0024 |
| 36 |
PORPHYRIA NON-ACUTE |
1 |
0.0023 |
| 37 |
TEMPORAL LOBE EPILEPSY |
1 |
0.0023 |
| 38 |
GINGIVAL BLISTER |
1 |
0.0023 |
| 39 |
EYELID INFECTION |
1 |
0.0023 |
| 40 |
BODY HEIGHT INCREASED |
1 |
0.0020 |
| 41 |
ROOT CANAL INFECTION |
1 |
0.0020 |
| 42 |
ACCIDENT AT HOME |
1 |
0.0019 |
| 43 |
HEPATIC ADENOMA |
1 |
0.0019 |
| 44 |
INFUSION SITE MASS |
2 |
0.0018 |
| 45 |
NERVE ROOT COMPRESSION |
1 |
0.0017 |
| 46 |
DEVICE MAINTENANCE ISSUE |
1 |
0.0017 |
| 47 |
URETHRAL PAIN |
1 |
0.0017 |
| 48 |
ANOXIC ENCEPHALOPATHY |
1 |
0.0016 |
| 49 |
MAGNETIC RESONANCE IMAGING HEAD ABNORMAL |
1 |
0.0015 |
| 50 |
DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED |
1 |
0.0015 |
| 51 |
INJECTION SITE EXFOLIATION |
1 |
0.0015 |
| 52 |
CEREBRAL CYST |
1 |
0.0015 |
| 53 |
PORPHYRIA ACUTE |
2 |
0.0014 |
| 54 |
SMALL FIBRE NEUROPATHY |
1 |
0.0014 |
| 55 |
INDIFFERENCE |
1 |
0.0013 |
| 56 |
QRS AXIS ABNORMAL |
1 |
0.0013 |
| 57 |
COAGULATION TEST ABNORMAL |
1 |
0.0013 |
| 58 |
BREAST CALCIFICATIONS |
1 |
0.0013 |
| 59 |
SIMPLE PARTIAL SEIZURES |
1 |
0.0012 |
| 60 |
BREAST OPERATION |
1 |
0.0012 |
| 61 |
VACCINATION COMPLICATION |
1 |
0.0012 |
| 62 |
POSTMENOPAUSAL HAEMORRHAGE |
3 |
0.0011 |
| 63 |
X-RAY ABNORMAL |
2 |
0.0011 |
| 64 |
TRAUMATIC INTRACRANIAL HAEMORRHAGE |
1 |
0.0011 |
| 65 |
ENTEROCOLITIS INFECTIOUS |
1 |
0.0011 |
| 66 |
VENOUS INJURY |
1 |
0.0011 |
| 67 |
VASCULAR PAIN |
1 |
0.0010 |
| 68 |
LYMPHADENECTOMY |
1 |
0.0010 |
| 69 |
HEMIANOPIA |
1 |
0.0010 |
| 70 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
2 |
0.0010 |
| 71 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
2 |
0.0010 |
| 72 |
ALLERGY TO ANIMAL |
1 |
0.0009 |
| 73 |
NEUROMYOPATHY |
1 |
0.0009 |
| 74 |
INTRACRANIAL VENOUS SINUS THROMBOSIS |
1 |
0.0009 |
| 75 |
VULVOVAGINAL DRYNESS |
3 |
0.0009 |
| 76 |
INFUSION SITE BRUISING |
2 |
0.0009 |
| 77 |
HEPATIC NEOPLASM |
3 |
0.0009 |
| 78 |
GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE |
1 |
0.0009 |
| 79 |
CRYPTORCHISM |
1 |
0.0009 |
| 80 |
DRUG EFFECT VARIABLE |
1 |
0.0009 |
| 81 |
DISLOCATION OF VERTEBRA |
2 |
0.0009 |
| 82 |
FOLATE DEFICIENCY |
1 |
0.0009 |
| 83 |
REFLUX GASTRITIS |
1 |
0.0008 |
| 84 |
APPLICATION SITE HYPERSENSITIVITY |
1 |
0.0008 |
| 85 |
INFUSION SITE WARMTH |
1 |
0.0008 |
| 86 |
POST-ACUTE COVID-19 SYNDROME |
1 |
0.0008 |
| 87 |
INTRA-ABDOMINAL HAEMATOMA |
1 |
0.0008 |
| 88 |
ALLERGY TO CHEMICALS |
1 |
0.0008 |
| 89 |
LUPUS VULGARIS |
1 |
0.0008 |
| 90 |
APPLICATION SITE EROSION |
1 |
0.0008 |
| 91 |
TUMOUR PAIN |
1 |
0.0008 |
| 92 |
NEUROMYELITIS OPTICA SPECTRUM DISORDER |
1 |
0.0007 |
| 93 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
1 |
0.0007 |
| 94 |
MAST CELL ACTIVATION SYNDROME |
1 |
0.0007 |
| 95 |
AUDITORY DISORDER |
1 |
0.0007 |
| 96 |
CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY |
1 |
0.0007 |
| 97 |
ANKLE OPERATION |
1 |
0.0007 |
| 98 |
BLOOD PARATHYROID HORMONE DECREASED |
1 |
0.0007 |
| 99 |
BREAST TENDERNESS |
5 |
0.0007 |
| 100 |
NON-CARDIAC CHEST PAIN |
2 |
0.0006 |
| 101 |
CYSTITIS INTERSTITIAL |
1 |
0.0006 |
| 102 |
GLYCOSYLATED HAEMOGLOBIN DECREASED |
1 |
0.0006 |
| 103 |
FACET JOINT SYNDROME |
2 |
0.0006 |
| 104 |
MUSCLE INJURY |
5 |
0.0006 |
| 105 |
TYMPANIC MEMBRANE PERFORATION |
1 |
0.0006 |
| 106 |
PUSTULAR PSORIASIS |
2 |
0.0006 |
| 107 |
INJECTION SITE OEDEMA |
1 |
0.0006 |
| 108 |
RETINITIS |
1 |
0.0006 |
| 109 |
MEDICAL DEVICE REMOVAL |
1 |
0.0006 |
| 110 |
PAPILLARY THYROID CANCER |
1 |
0.0006 |
| 111 |
EXTREMITY NECROSIS |
1 |
0.0006 |
| 112 |
OTORRHOEA |
1 |
0.0006 |
| 113 |
MASTECTOMY |
1 |
0.0006 |
| 114 |
VERTIGO POSITIONAL |
1 |
0.0006 |
| 115 |
BREAST DISCHARGE |
1 |
0.0006 |
| 116 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 117 |
SKIN HYPOPIGMENTATION |
1 |
0.0006 |
| 118 |
BREAST CYST |
1 |
0.0006 |
| 119 |
APPLICATION SITE DISCOMFORT |
1 |
0.0006 |
| 120 |
CAROTID ARTERY OCCLUSION |
2 |
0.0005 |
| 121 |
SUSPECTED PRODUCT QUALITY ISSUE |
1 |
0.0005 |
| 122 |
CEREBROSPINAL FLUID LEAKAGE |
1 |
0.0005 |
| 123 |
LYMPH NODE PAIN |
1 |
0.0005 |
| 124 |
RADIOTHERAPY |
1 |
0.0005 |
| 125 |
PATIENT DISSATISFACTION WITH TREATMENT |
1 |
0.0005 |
| 126 |
THERAPEUTIC PRODUCT INEFFECTIVE |
2 |
0.0005 |
| 127 |
ALLERGIC REACTION TO EXCIPIENT |
1 |
0.0005 |
| 128 |
BLEPHARITIS |
2 |
0.0005 |
| 129 |
SMALL INTESTINAL HAEMORRHAGE |
1 |
0.0005 |
| 130 |
LIBIDO INCREASED |
1 |
0.0005 |
| 131 |
PERIPHERAL VENOUS DISEASE |
2 |
0.0005 |
| 132 |
INFUSION SITE SWELLING |
3 |
0.0005 |
| 133 |
BREAST PAIN |
5 |
0.0005 |
| 134 |
OLIGOMENORRHOEA |
1 |
0.0005 |
| 135 |
DIABETIC NEPHROPATHY |
1 |
0.0005 |
| 136 |
RHEUMATIC FEVER |
2 |
0.0004 |
| 137 |
LICHEN PLANUS |
1 |
0.0004 |
| 138 |
ACUTE FEBRILE NEUTROPHILIC DERMATOSIS |
1 |
0.0004 |
| 139 |
ROSACEA |
2 |
0.0004 |
| 140 |
SINUS PAIN |
1 |
0.0004 |
| 141 |
SINUS OPERATION |
1 |
0.0004 |
| 142 |
PAINFUL RESPIRATION |
1 |
0.0004 |
| 143 |
METRORRHAGIA |
7 |
0.0004 |
| 144 |
GASTROINTESTINAL SOUNDS ABNORMAL |
2 |
0.0004 |
| 145 |
STEM CELL TRANSPLANT |
1 |
0.0004 |
| 146 |
AMMONIA INCREASED |
2 |
0.0004 |
| 147 |
MENOPAUSE |
1 |
0.0004 |
| 148 |
ACTINIC KERATOSIS |
1 |
0.0004 |
| 149 |
PRODUCT ADMINISTRATION INTERRUPTED |
3 |
0.0004 |
| 150 |
ANIMAL BITE |
1 |
0.0004 |
| 151 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 152 |
EAR CONGESTION |
1 |
0.0004 |
| 153 |
APPLICATION SITE HAEMORRHAGE |
1 |
0.0004 |
| 154 |
TENOSYNOVITIS |
1 |
0.0004 |
| 155 |
INTERMENSTRUAL BLEEDING |
2 |
0.0004 |
| 156 |
ELECTRIC SHOCK SENSATION |
1 |
0.0004 |
| 157 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 158 |
PERIORBITAL SWELLING |
2 |
0.0004 |
| 159 |
SCAB |
4 |
0.0004 |
| 160 |
FIBULA FRACTURE |
1 |
0.0003 |
| 161 |
EYELID MARGIN CRUSTING |
1 |
0.0003 |
| 162 |
HOT FLUSH |
25 |
0.0003 |
| 163 |
LIP DRY |
3 |
0.0003 |
| 164 |
EYELIDS PRURITUS |
1 |
0.0003 |
| 165 |
SWOLLEN JOINT COUNT INCREASED |
1 |
0.0003 |
| 166 |
C-REACTIVE PROTEIN ABNORMAL |
2 |
0.0003 |
| 167 |
SKIN EROSION |
1 |
0.0003 |
| 168 |
BREAST CANCER STAGE III |
2 |
0.0003 |
| 169 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
2 |
0.0003 |
| 170 |
VITAMIN D DEFICIENCY |
3 |
0.0003 |
| 171 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 172 |
INFUSION SITE HAEMORRHAGE |
1 |
0.0003 |
| 173 |
WALKING AID USER |
2 |
0.0003 |
| 174 |
PRODUCT FORMULATION ISSUE |
2 |
0.0003 |
| 175 |
NEAR DEATH EXPERIENCE |
1 |
0.0003 |
| 176 |
LYME DISEASE |
1 |
0.0003 |
| 177 |
HEPATIC CYST |
1 |
0.0003 |
| 178 |
BRONCHOPNEUMONIA |
1 |
0.0003 |
| 179 |
CERVICAL VERTEBRAL FRACTURE |
1 |
0.0003 |
| 180 |
ERYTHEMA NODOSUM |
1 |
0.0003 |
| 181 |
BONE EROSION |
1 |
0.0003 |
| 182 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 183 |
FRUSTRATION |
1 |
0.0003 |
| 184 |
MONOCYTE COUNT INCREASED |
1 |
0.0003 |
| 185 |
SEBORRHOEA |
1 |
0.0003 |
| 186 |
DUODENAL ULCER PERFORATION |
2 |
0.0003 |
| 187 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
1 |
0.0003 |
| 188 |
AUTOIMMUNE THYROIDITIS |
1 |
0.0003 |
| 189 |
CHEMOTHERAPY |
1 |
0.0003 |
| 190 |
PARANASAL SINUS DISCOMFORT |
1 |
0.0003 |
| 191 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 192 |
SKIN ODOUR ABNORMAL |
1 |
0.0003 |
| 193 |
VAGINAL HAEMORRHAGE |
11 |
0.0003 |
| 194 |
HYPERPHAGIA |
1 |
0.0003 |
| 195 |
NIGHT SWEATS |
8 |
0.0002 |
| 196 |
BURSITIS |
3 |
0.0002 |
| 197 |
APPLICATION SITE EXFOLIATION |
1 |
0.0002 |
| 198 |
UPPER-AIRWAY COUGH SYNDROME |
2 |
0.0002 |
| 199 |
THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION |
1 |
0.0002 |
| 200 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 201 |
POOR PERIPHERAL CIRCULATION |
1 |
0.0002 |
| 202 |
LEFT VENTRICULAR HYPERTROPHY |
1 |
0.0002 |
| 203 |
HEPATIC LESION |
1 |
0.0002 |
| 204 |
IMMOBILE |
1 |
0.0002 |
| 205 |
HAEMORRHAGIC ANAEMIA |
1 |
0.0002 |
| 206 |
GRIP STRENGTH DECREASED |
2 |
0.0002 |
| 207 |
LIGAMENT RUPTURE |
1 |
0.0002 |
| 208 |
VULVOVAGINAL DISCOMFORT |
1 |
0.0002 |
| 209 |
PHYSICAL DISABILITY |
1 |
0.0002 |
| 210 |
BRAIN NEOPLASM MALIGNANT |
1 |
0.0002 |
| 211 |
SINUS CONGESTION |
3 |
0.0002 |
| 212 |
EXOSTOSIS |
2 |
0.0002 |
| 213 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
2 |
0.0002 |
| 214 |
NEPHROGENIC ANAEMIA |
1 |
0.0002 |
| 215 |
RENAL FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 216 |
UMBILICAL HERNIA |
1 |
0.0002 |
| 217 |
TIBIA FRACTURE |
1 |
0.0002 |
| 218 |
VAGINAL INFECTION |
1 |
0.0002 |
| 219 |
BLOOD PROLACTIN INCREASED |
1 |
0.0002 |
| 220 |
SEASONAL ALLERGY |
3 |
0.0002 |
| 221 |
SKIN ABRASION |
1 |
0.0002 |
| 222 |
MEDICATION RESIDUE PRESENT |
1 |
0.0002 |
| 223 |
HYPERCHOLESTEROLAEMIA |
2 |
0.0002 |
| 224 |
AUTOIMMUNE DISORDER |
2 |
0.0002 |
| 225 |
COELIAC DISEASE |
2 |
0.0002 |
| 226 |
BODY TEMPERATURE DECREASED |
2 |
0.0002 |
| 227 |
NASAL POLYPS |
1 |
0.0002 |
| 228 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 229 |
LIGAMENT SPRAIN |
2 |
0.0002 |
| 230 |
DIABETIC NEUROPATHY |
1 |
0.0002 |
| 231 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 232 |
SALIVARY HYPERSECRETION |
2 |
0.0002 |
| 233 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 234 |
HIP ARTHROPLASTY |
3 |
0.0002 |
| 235 |
EAR DISCOMFORT |
2 |
0.0002 |
| 236 |
PRODUCT COLOUR ISSUE |
1 |
0.0002 |
| 237 |
HELICOBACTER INFECTION |
2 |
0.0002 |
| 238 |
CEREBRAL ISCHAEMIA |
1 |
0.0002 |
| 239 |
BRAIN FOG |
3 |
0.0002 |
| 240 |
FOLLICULITIS |
2 |
0.0002 |
| 241 |
OBESITY |
3 |
0.0002 |
| 242 |
SCIATICA |
3 |
0.0002 |
| 243 |
BODY HEIGHT DECREASED |
2 |
0.0002 |
| 244 |
IRRITABLE BOWEL SYNDROME |
4 |
0.0002 |
| 245 |
BRUXISM |
1 |
0.0002 |
| 246 |
GINGIVITIS |
1 |
0.0002 |
| 247 |
STRESS FRACTURE |
1 |
0.0002 |
| 248 |
TIC |
1 |
0.0002 |
| 249 |
FAECALOMA |
1 |
0.0002 |
| 250 |
FOOT DEFORMITY |
2 |
0.0002 |
| 251 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 252 |
PERICARDITIS |
3 |
0.0002 |
| 253 |
VISUAL DISTURBANCE |
1 |
0.0002 |
| 254 |
UPPER RESPIRATORY TRACT INFECTION |
8 |
0.0002 |
| 255 |
RHEUMATOID FACTOR POSITIVE |
1 |
0.0002 |
| 256 |
SKIN WARM |
1 |
0.0002 |
| 257 |
INGUINAL HERNIA |
1 |
0.0002 |
| 258 |
TENSION |
1 |
0.0002 |
| 259 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 260 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 261 |
MIDDLE INSOMNIA |
3 |
0.0002 |
| 262 |
PEMPHIGUS |
2 |
0.0002 |
| 263 |
DERMATITIS ALLERGIC |
2 |
0.0002 |
| 264 |
MUSCLE ATROPHY |
2 |
0.0002 |
| 265 |
GALACTORRHOEA |
1 |
0.0002 |
| 266 |
BLOOD PRESSURE SYSTOLIC INCREASED |
3 |
0.0002 |
| 267 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 268 |
SOMNAMBULISM |
1 |
0.0002 |
| 269 |
DYSGRAPHIA |
1 |
0.0002 |
| 270 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 271 |
APPETITE DISORDER |
1 |
0.0002 |
| 272 |
MENSTRUATION IRREGULAR |
4 |
0.0001 |
| 273 |
JOINT RANGE OF MOTION DECREASED |
2 |
0.0001 |
| 274 |
PRODUCT ADMINISTRATION ERROR |
3 |
0.0001 |
| 275 |
POSTOPERATIVE WOUND INFECTION |
1 |
0.0001 |
| 276 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 277 |
IMPAIRED GASTRIC EMPTYING |
2 |
0.0001 |
| 278 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
7 |
0.0001 |
| 279 |
APPLICATION SITE RASH |
2 |
0.0001 |
| 280 |
ROAD TRAFFIC ACCIDENT |
6 |
0.0001 |
| 281 |
APHONIA |
2 |
0.0001 |
| 282 |
MASS |
2 |
0.0001 |
| 283 |
KNEE ARTHROPLASTY |
3 |
0.0001 |
| 284 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 285 |
THERMAL BURN |
1 |
0.0001 |
| 286 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 287 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
1 |
0.0001 |
| 288 |
PANIC REACTION |
1 |
0.0001 |
| 289 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 290 |
HYPOKINESIA |
2 |
0.0001 |
| 291 |
GASTROENTERITIS |
2 |
0.0001 |
| 292 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 293 |
UTERINE LEIOMYOMA |
1 |
0.0001 |
| 294 |
BLINDNESS TRANSIENT |
1 |
0.0001 |
| 295 |
ARTHROPOD BITE |
1 |
0.0001 |
| 296 |
FEELING DRUNK |
1 |
0.0001 |
| 297 |
SUNBURN |
1 |
0.0001 |
| 298 |
KETOACIDOSIS |
1 |
0.0001 |
| 299 |
GENERAL SYMPTOM |
1 |
0.0001 |
| 300 |
BLOOD POTASSIUM DECREASED |
4 |
0.0001 |
| 301 |
PEMPHIGOID |
1 |
0.0001 |
| 302 |
APPLICATION SITE PRURITUS |
3 |
0.0001 |
| 303 |
PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 304 |
FOOD ALLERGY |
1 |
0.0001 |
| 305 |
TENDONITIS |
2 |
0.0001 |
| 306 |
BLOOD CHOLESTEROL INCREASED |
6 |
0.0001 |
| 307 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 308 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 309 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 310 |
FURUNCLE |
1 |
0.0001 |
| 311 |
RENAL CYST |
1 |
0.0001 |
| 312 |
FIBROMYALGIA |
3 |
0.0001 |
| 313 |
CEREBRAL INFARCTION |
3 |
0.0001 |
| 314 |
EMBOLISM |
1 |
0.0001 |
| 315 |
BLOOD UREA INCREASED |
2 |
0.0001 |
| 316 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0001 |
| 317 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 318 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
2 |
0.0001 |
| 319 |
INADEQUATE ANALGESIA |
1 |
0.0001 |
| 320 |
SINUSITIS |
12 |
0.0001 |
| 321 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 322 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 323 |
PSYCHOLOGICAL TRAUMA |
1 |
0.0001 |
| 324 |
CARDIAC MURMUR |
1 |
0.0001 |
| 325 |
HYSTERECTOMY |
1 |
0.0001 |
| 326 |
MIGRAINE |
11 |
0.0001 |
| 327 |
SKIN SWELLING |
1 |
0.0001 |
| 328 |
APPLICATION SITE ERYTHEMA |
3 |
0.0001 |
| 329 |
RASH MACULAR |
4 |
0.0001 |
| 330 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 331 |
EAR INFECTION |
3 |
0.0001 |
| 332 |
HAEMARTHROSIS |
1 |
0.0001 |
| 333 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 334 |
MOBILITY DECREASED |
8 |
0.0001 |
| 335 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 336 |
TOOTHACHE |
2 |
0.0001 |
| 337 |
OPTIC NEURITIS |
1 |
0.0001 |
| 338 |
RESTLESS LEGS SYNDROME |
2 |
0.0001 |
| 339 |
END STAGE RENAL DISEASE |
2 |
0.0001 |
| 340 |
SKIN LESION |
3 |
0.0001 |
| 341 |
NERVE COMPRESSION |
1 |
0.0001 |
| 342 |
BREAST CANCER STAGE I |
1 |
0.0001 |
| 343 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 344 |
FEELING COLD |
3 |
0.0001 |
| 345 |
BREAST CANCER |
10 |
0.0001 |
| 346 |
DEFORMITY |
1 |
0.0001 |
| 347 |
BLISTER |
6 |
0.0001 |
| 348 |
HEPATIC CIRRHOSIS |
2 |
0.0001 |
| 349 |
FOOT FRACTURE |
2 |
0.0001 |
| 350 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 351 |
GASTRIC ULCER |
2 |
0.0001 |
| 352 |
PULMONARY FIBROSIS |
2 |
0.0001 |
| 353 |
WHITE BLOOD CELL COUNT INCREASED |
4 |
0.0001 |
| 354 |
PRODUCT SUBSTITUTION ISSUE |
6 |
0.0001 |
| 355 |
LOWER LIMB FRACTURE |
2 |
0.0001 |
| 356 |
ATELECTASIS |
1 |
0.0001 |
| 357 |
ORAL HERPES |
2 |
0.0001 |
| 358 |
SKIN FISSURES |
2 |
0.0001 |
| 359 |
MENORRHAGIA |
2 |
0.0001 |
| 360 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 361 |
THERAPY CHANGE |
1 |
0.0001 |
| 362 |
LABORATORY TEST ABNORMAL |
3 |
0.0001 |
| 363 |
DISABILITY |
2 |
0.0001 |
| 364 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 365 |
DRY THROAT |
1 |
0.0001 |
| 366 |
INJECTION SITE RASH |
3 |
0.0001 |
| 367 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 368 |
SKELETAL INJURY |
1 |
0.0001 |
| 369 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 370 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
0.0001 |
| 371 |
DERMATITIS ATOPIC |
5 |
0.0001 |
| 372 |
SCRATCH |
1 |
0.0001 |
| 373 |
BRONCHITIS |
7 |
0.0001 |
| 374 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 375 |
OSTEOARTHRITIS |
4 |
0.0001 |
| 376 |
JOINT INJURY |
2 |
0.0001 |
| 377 |
IMPAIRED WORK ABILITY |
2 |
0.0001 |
| 378 |
SKIN LACERATION |
1 |
0.0001 |
| 379 |
WOUND INFECTION |
1 |
0.0001 |
| 380 |
GASTROINTESTINAL PAIN |
1 |
0.0001 |
| 381 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
2 |
0.0001 |
| 382 |
VIRAL INFECTION |
3 |
0.0001 |
| 383 |
GLOSSODYNIA |
2 |
0.0001 |
| 384 |
EYE PRURITUS |
3 |
0.0001 |
| 385 |
SNEEZING |
2 |
0.0001 |
| 386 |
SKIN INFECTION |
1 |
0.0001 |
| 387 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 388 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 389 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 390 |
ILLNESS |
9 |
0.0001 |
| 391 |
MYOCARDITIS |
1 |
0.0001 |
| 392 |
MADAROSIS |
1 |
0.0001 |
| 393 |
EYELID OEDEMA |
1 |
0.0001 |
| 394 |
INJURY |
6 |
0.0001 |
| 395 |
SPINAL PAIN |
1 |
0.0001 |
| 396 |
SURGERY |
5 |
0.0001 |
| 397 |
LYMPHADENOPATHY |
3 |
0.0001 |
| 398 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 399 |
DISEASE RECURRENCE |
4 |
0.0001 |
| 400 |
PRODUCTIVE COUGH |
4 |
0.0001 |
| 401 |
FEELING HOT |
5 |
0.0001 |
| 402 |
LIVER INJURY |
2 |
0.0001 |
| 403 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 404 |
SPINAL OPERATION |
1 |
0.0001 |
| 405 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 406 |
DYSGEUSIA |
6 |
0.0001 |
| 407 |
APPLICATION SITE IRRITATION |
1 |
0.0001 |
| 408 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 409 |
ABDOMINAL PAIN LOWER |
2 |
0.0001 |
| 410 |
HEPATITIS |
2 |
0.0001 |
| 411 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 412 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 413 |
INFLAMMATION |
4 |
0.0001 |
| 414 |
RHINORRHOEA |
5 |
0.0001 |
| 415 |
DIPLOPIA |
2 |
0.0001 |
| 416 |
ABDOMINAL DISTENSION |
8 |
0.0001 |
| 417 |
MUSCULOSKELETAL PAIN |
4 |
0.0001 |
| 418 |
ARTHRITIS |
6 |
0.0001 |
| 419 |
HAND DEFORMITY |
1 |
0.0001 |
| 420 |
TOOTH INFECTION |
1 |
0.0001 |
| 421 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 422 |
DYSMENORRHOEA |
1 |
0.0001 |
| 423 |
ADVERSE REACTION |
1 |
0.0001 |
| 424 |
FREQUENT BOWEL MOVEMENTS |
2 |
0.0001 |
| 425 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 426 |
PSORIATIC ARTHROPATHY |
3 |
0.0001 |
| 427 |
COORDINATION ABNORMAL |
1 |
0.0001 |
| 428 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 429 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 430 |
DYSPEPSIA |
7 |
0.0001 |
| 431 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 432 |
EYE PAIN |
4 |
0.0001 |
| 433 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 434 |
DEPRESSION |
16 |
0.0001 |
| 435 |
BRONCHOSPASM |
1 |
0.0001 |
| 436 |
THERAPY INTERRUPTED |
5 |
0.0001 |
| 437 |
PARALYSIS |
1 |
0.0001 |
| 438 |
ANGINA PECTORIS |
2 |
0.0001 |
| 439 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 440 |
INJECTION SITE HAEMATOMA |
1 |
0.0001 |
| 441 |
PALPITATIONS |
8 |
0.0001 |
| 442 |
PAIN IN EXTREMITY |
20 |
0.0001 |
| 443 |
PSYCHOTIC DISORDER |
2 |
0.0001 |
| 444 |
RENAL INJURY |
2 |
0.0001 |
| 445 |
PULMONARY MASS |
1 |
0.0001 |
| 446 |
HYPOAESTHESIA |
10 |
0.0001 |
| 447 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 448 |
VERTIGO |
4 |
0.0001 |
| 449 |
DISCOMFORT |
4 |
0.0001 |
| 450 |
INSURANCE ISSUE |
1 |
0.0001 |
| 451 |
MUSCLE SPASMS |
12 |
0.0001 |
| 452 |
EMOTIONAL DISORDER |
2 |
0.0001 |
| 453 |
FEMUR FRACTURE |
2 |
0.0001 |
| 454 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 455 |
ULCER |
1 |
0.0001 |
| 456 |
COVID-19 |
11 |
0.0001 |
| 457 |
CONTUSION |
6 |
0.0001 |
| 458 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 459 |
SWELLING FACE |
4 |
0.0001 |
| 460 |
PRODUCT DOSE OMISSION |
4 |
0.0001 |
| 461 |
LUNG DISORDER |
3 |
0.0001 |
| 462 |
IMPAIRED HEALING |
2 |
0.0001 |
| 463 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 464 |
DRY EYE |
3 |
0.0001 |
| 465 |
FUNGAL INFECTION |
2 |
0.0001 |
| 466 |
URINARY RETENTION |
2 |
0.0001 |
| 467 |
TYPE 2 DIABETES MELLITUS |
2 |
0.0001 |
| 468 |
FLUID RETENTION |
3 |
0.0001 |
| 469 |
PRODUCT QUALITY ISSUE |
8 |
0.0001 |
| 470 |
SCAR |
1 |
0.0001 |
| 471 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 472 |
JOINT SWELLING |
7 |
0.0001 |
| 473 |
BALANCE DISORDER |
5 |
0.0001 |
| 474 |
NIGHTMARE |
2 |
0.0001 |
| 475 |
DELIRIUM |
2 |
0.0001 |
| 476 |
NERVOUSNESS |
3 |
0.0001 |
| 477 |
HAEMORRHAGE |
6 |
0.0001 |
| 478 |
SPEECH DISORDER |
3 |
0.0001 |
| 479 |
SYRINGE ISSUE |
1 |
0.0001 |
| 480 |
MUSCULOSKELETAL STIFFNESS |
5 |
0.0001 |
| 481 |
BURNING SENSATION |
4 |
0.0001 |
| 482 |
HEART RATE DECREASED |
2 |
0.0001 |
| 483 |
SLEEP DISORDER |
4 |
0.0001 |
| 484 |
VISUAL IMPAIRMENT |
7 |
0.0001 |
| 485 |
TACHYCARDIA |
5 |
0.0001 |
| 486 |
ANXIETY |
16 |
0.0001 |
| 487 |
GALLBLADDER DISORDER |
1 |
0.0001 |
| 488 |
DRUG EFFECT DECREASED |
3 |
0.0001 |
| 489 |
SYNOVITIS |
1 |
0.0001 |
| 490 |
OSTEOMYELITIS |
1 |
0.0001 |
| 491 |
HYPERGLYCAEMIA |
2 |
0.0001 |
| 492 |
BONE DISORDER |
1 |
0.0001 |
| 493 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 494 |
INJECTION SITE MASS |
2 |
0.0001 |
| 495 |
ARTHROPATHY |
3 |
0.0001 |
| 496 |
NECK PAIN |
3 |
0.0001 |
| 497 |
WEIGHT INCREASED |
12 |
0.0001 |
| 498 |
SWELLING |
5 |
0.0001 |
| 499 |
PHOTOPHOBIA |
1 |
0.0001 |
| 500 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 501 |
COLITIS |
2 |
0.0001 |
| 502 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 503 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 504 |
EYE IRRITATION |
3 |
0.0001 |
| 505 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 506 |
PLASMA CELL MYELOMA |
2 |
0.0001 |
| 507 |
KIDNEY INFECTION |
1 |
0.0001 |
| 508 |
ALOPECIA |
10 |
0.0001 |
| 509 |
INJECTION SITE BRUISING |
4 |
0.0001 |
| 510 |
PREGNANCY |
1 |
0.0000 |
| 511 |
IRRITABILITY |
3 |
0.0000 |
| 512 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 513 |
STOMATITIS |
3 |
0.0000 |
| 514 |
DRY MOUTH |
4 |
0.0000 |
| 515 |
BLINDNESS |
2 |
0.0000 |
| 516 |
INSOMNIA |
13 |
0.0000 |
| 517 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 518 |
OSTEOPOROSIS |
2 |
0.0000 |
| 519 |
HYPERSENSITIVITY |
9 |
0.0000 |
| 520 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 521 |
DERMATITIS |
1 |
0.0000 |
| 522 |
MYALGIA |
8 |
0.0000 |
| 523 |
RETCHING |
1 |
0.0000 |
| 524 |
RECTAL HAEMORRHAGE |
2 |
0.0000 |
| 525 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 526 |
AMNESIA |
3 |
0.0000 |
| 527 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 528 |
BLOOD PRESSURE INCREASED |
7 |
0.0000 |
| 529 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 530 |
MELAENA |
1 |
0.0000 |
| 531 |
INFUSION RELATED REACTION |
3 |
0.0000 |
| 532 |
ANGIOEDEMA |
2 |
0.0000 |
| 533 |
BLOOD PRESSURE DECREASED |
3 |
0.0000 |
| 534 |
LIVER DISORDER |
2 |
0.0000 |
| 535 |
INFLUENZA |
5 |
0.0000 |
| 536 |
COLITIS ULCERATIVE |
2 |
0.0000 |
| 537 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 538 |
THROAT IRRITATION |
2 |
0.0000 |
| 539 |
PARAESTHESIA |
7 |
0.0000 |
| 540 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 541 |
PRODUCT USE IN UNAPPROVED INDICATION |
11 |
0.0000 |
| 542 |
ASTHMA |
5 |
0.0000 |
| 543 |
RHEUMATOID ARTHRITIS |
5 |
0.0000 |
| 544 |
LOWER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 545 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 546 |
ERYTHEMA |
9 |
0.0000 |
| 547 |
ABDOMINAL PAIN UPPER |
9 |
0.0000 |
| 548 |
TINNITUS |
2 |
0.0000 |
| 549 |
ADVERSE EVENT |
4 |
0.0000 |
| 550 |
NASOPHARYNGITIS |
8 |
0.0000 |
| 551 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 552 |
ARTHRALGIA |
18 |
0.0000 |
| 553 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 554 |
CONDITION AGGRAVATED |
13 |
0.0000 |
| 555 |
HYPERTENSION |
9 |
0.0000 |
| 556 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 557 |
GAIT DISTURBANCE |
8 |
0.0000 |
| 558 |
PRURITUS |
16 |
0.0000 |
| 559 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 560 |
LOCALISED INFECTION |
1 |
0.0000 |
| 561 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 562 |
NEURALGIA |
1 |
0.0000 |
| 563 |
ATRIAL FIBRILLATION |
4 |
0.0000 |
| 564 |
PRODUCT DOSE OMISSION ISSUE |
12 |
0.0000 |
| 565 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 566 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 567 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 568 |
MYOCARDIAL INFARCTION |
7 |
0.0000 |
| 569 |
HEADACHE |
25 |
0.0000 |
| 570 |
UNEVALUABLE EVENT |
3 |
0.0000 |
| 571 |
ACNE |
3 |
0.0000 |
| 572 |
HAEMATEMESIS |
1 |
0.0000 |
| 573 |
INCORRECT DOSE ADMINISTERED |
9 |
0.0000 |
| 574 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 575 |
CHEST DISCOMFORT |
4 |
0.0000 |
| 576 |
PERIPHERAL SWELLING |
6 |
0.0000 |
| 577 |
HYPERHIDROSIS |
5 |
0.0000 |
| 578 |
BACK PAIN |
9 |
0.0000 |
| 579 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 580 |
PSORIASIS |
5 |
0.0000 |
| 581 |
DEAFNESS |
1 |
0.0000 |
| 582 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 583 |
GASTRITIS |
1 |
0.0000 |
| 584 |
DEPRESSED MOOD |
2 |
0.0000 |
| 585 |
CHEST PAIN |
7 |
0.0000 |
| 586 |
DRY SKIN |
5 |
0.0000 |
| 587 |
RASH PRURITIC |
2 |
0.0000 |
| 588 |
OEDEMA |
2 |
0.0000 |
| 589 |
LIMB INJURY |
1 |
0.0000 |
| 590 |
INFLUENZA LIKE ILLNESS |
3 |
0.0000 |
| 591 |
MEMORY IMPAIRMENT |
5 |
0.0000 |
| 592 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 593 |
DIVERTICULITIS |
1 |
0.0000 |
| 594 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 595 |
WOUND |
1 |
0.0000 |
| 596 |
ABDOMINAL DISCOMFORT |
6 |
0.0000 |
| 597 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 598 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 599 |
PAIN IN JAW |
1 |
0.0000 |
| 600 |
URINARY TRACT INFECTION |
6 |
0.0000 |
| 601 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 602 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 603 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 604 |
SOMNOLENCE |
7 |
0.0000 |
| 605 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
1 |
0.0000 |
| 606 |
GENERAL PHYSICAL HEALTH DETERIORATION |
4 |
0.0000 |
| 607 |
INFECTION |
5 |
0.0000 |
| 608 |
RASH |
15 |
0.0000 |
| 609 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 610 |
NEEDLE ISSUE |
1 |
0.0000 |
| 611 |
BONE PAIN |
2 |
0.0000 |
| 612 |
NASAL CONGESTION |
2 |
0.0000 |
| 613 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 614 |
WHEEZING |
2 |
0.0000 |
| 615 |
GASTROINTESTINAL DISORDER |
3 |
0.0000 |
| 616 |
ADVERSE DRUG REACTION |
3 |
0.0000 |
| 617 |
FATIGUE |
26 |
0.0000 |
| 618 |
APHASIA |
1 |
0.0000 |
| 619 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 620 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 621 |
ILL-DEFINED DISORDER |
2 |
0.0000 |
| 622 |
EPILEPSY |
1 |
0.0000 |
| 623 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 624 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 625 |
INJECTION SITE ERYTHEMA |
4 |
0.0000 |
| 626 |
CONSTIPATION |
7 |
0.0000 |
| 627 |
COUGH |
9 |
0.0000 |
| 628 |
DIZZINESS |
16 |
0.0000 |
| 629 |
HEAD INJURY |
1 |
0.0000 |
| 630 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 631 |
CYSTITIS |
1 |
0.0000 |
| 632 |
MOOD SWINGS |
1 |
0.0000 |
| 633 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 634 |
LOSS OF CONSCIOUSNESS |
4 |
0.0000 |
| 635 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 636 |
HIP FRACTURE |
1 |
0.0000 |
| 637 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 638 |
BLOOD CREATININE INCREASED |
2 |
0.0000 |
| 639 |
NAUSEA |
24 |
0.0000 |
| 640 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 641 |
HEART RATE INCREASED |
3 |
0.0000 |
| 642 |
RENAL FAILURE |
4 |
0.0000 |
| 643 |
LIP SWELLING |
1 |
0.0000 |
| 644 |
SKIN DISORDER |
1 |
0.0000 |
| 645 |
GAIT INABILITY |
1 |
0.0000 |
| 646 |
INJECTION SITE PRURITUS |
2 |
0.0000 |
| 647 |
URTICARIA |
5 |
0.0000 |
| 648 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 649 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 650 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 651 |
ASTHENIA |
11 |
0.0000 |
| 652 |
FEELING ABNORMAL |
7 |
0.0000 |
| 653 |
MULTIPLE SCLEROSIS RELAPSE |
2 |
0.0000 |
| 654 |
VISION BLURRED |
4 |
0.0000 |
| 655 |
WEIGHT DECREASED |
8 |
0.0000 |
| 656 |
HYPOXIA |
1 |
0.0000 |
| 657 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 658 |
PRODUCT ADHESION ISSUE |
1 |
0.0000 |
| 659 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 660 |
PAIN |
17 |
0.0000 |
| 661 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 662 |
PANIC ATTACK |
1 |
0.0000 |
| 663 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 664 |
UNDERDOSE |
2 |
0.0000 |
| 665 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 666 |
DRUG INEFFECTIVE |
36 |
0.0000 |
| 667 |
AGITATION |
2 |
0.0000 |
| 668 |
DYSURIA |
1 |
0.0000 |
| 669 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 670 |
EPISTAXIS |
2 |
0.0000 |
| 671 |
DYSARTHRIA |
1 |
0.0000 |
| 672 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 673 |
DYSPNOEA |
15 |
0.0000 |
| 674 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 675 |
INJECTION SITE SWELLING |
2 |
0.0000 |
| 676 |
ABDOMINAL PAIN |
6 |
0.0000 |
| 677 |
DISORIENTATION |
1 |
0.0000 |
| 678 |
DRUG INTERACTION |
4 |
0.0000 |
| 679 |
PNEUMONIA |
8 |
0.0000 |
| 680 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 681 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 682 |
TREATMENT FAILURE |
2 |
0.0000 |
| 683 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 684 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 685 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 686 |
CEREBROVASCULAR ACCIDENT |
4 |
0.0000 |
| 687 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 688 |
INJECTION SITE PAIN |
7 |
0.0000 |
| 689 |
DEVICE ISSUE |
2 |
0.0000 |
| 690 |
SUICIDAL IDEATION |
2 |
0.0000 |
| 691 |
DIARRHOEA |
14 |
0.0000 |
| 692 |
HYPOKALAEMIA |
1 |
0.0000 |
| 693 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 694 |
DYSPHAGIA |
2 |
0.0000 |
| 695 |
COMA |
1 |
0.0000 |
| 696 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 697 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 698 |
MALAISE |
9 |
0.0000 |
| 699 |
SYNCOPE |
2 |
0.0000 |
| 700 |
CELLULITIS |
1 |
0.0000 |
| 701 |
FLUSHING |
2 |
0.0000 |
| 702 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 703 |
ECZEMA |
1 |
0.0000 |
| 704 |
PANCREATITIS |
1 |
0.0000 |
| 705 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 706 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 707 |
CONFUSIONAL STATE |
3 |
0.0000 |
| 708 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 709 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 710 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 711 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 712 |
TREMOR |
3 |
0.0000 |
| 713 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 714 |
SEIZURE |
2 |
0.0000 |
| 715 |
DYSPHONIA |
1 |
0.0000 |
| 716 |
CATARACT |
1 |
0.0000 |
| 717 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 718 |
ANAEMIA |
3 |
0.0000 |
| 719 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 720 |
FALL |
5 |
0.0000 |
| 721 |
NEOPLASM MALIGNANT |
1 |
0.0000 |
| 722 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 723 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 724 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
1 |
0.0000 |
| 725 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 726 |
HALLUCINATION |
1 |
0.0000 |
| 727 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 728 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 729 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 730 |
VOMITING |
6 |
0.0000 |
| 731 |
OFF LABEL USE |
11 |
0.0000 |
| 732 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 733 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 734 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 735 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 736 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 737 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 738 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 739 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 740 |
CARDIAC DISORDER |
1 |
0.0000 |
| 741 |
PRODUCT USE ISSUE |
2 |
0.0000 |
| 742 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 743 |
HYPOTENSION |
2 |
0.0000 |
| 744 |
SEPSIS |
1 |
0.0000 |
| 745 |
DECREASED APPETITE |
2 |
0.0000 |
| 746 |
CHILLS |
1 |
0.0000 |
| 747 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 748 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 749 |
DEHYDRATION |
1 |
0.0000 |
| 750 |
PYREXIA |
2 |
0.0000 |
| 751 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 752 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 753 |
OVERDOSE |
1 |
0.0000 |
| 754 |
DEATH |
2 |
0.0000 |